SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-136721
Filing Date
2024-05-13
Accepted
2024-05-13 07:48:42
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d807728d424b5.htm 424B5 413095
2 GRAPHIC g807728g01g01.jpg GRAPHIC 58950
3 GRAPHIC g807728g07g07.jpg GRAPHIC 46406
4 GRAPHIC g807728g08g08.jpg GRAPHIC 55529
  Complete submission text file 0001193125-24-136721.txt   630855
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277169 | Film No.: 24936912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)